1. Gazzaruso C: Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment. Expert Rev Cardiovasc Ther 2006, 4:173–180.
2. Martin EK, Cooper A, McGing E, et al.: Carrying short-acting nitrates is not a contra-indication to the use of PDE5 inhibitors. Poster presented at the British Association of Urological Surgeons (BAUS) Conference, Harrogate, UK, June 2004. Accessible at http://www.urotoday.com/287/conference_reports/baus_2004/baus_2004_conference__penile_cancer_and_erectile_dysfunction.html . Accessed June 30, 2006.
3. Parker JD, Bart BA, Webb D, et al.: A double-blind, placebo-controlled, crossover study of the safety of I9 intravenous glyceryl trinitrate after administration of sildenafil citrate to men with coronary artery disease [abstract no 862-61]. J Am Coll Cardiol 2005, 45:250A.
4. Scales CD, Curtis LH, Woosley RG, et al.: Co-prescription of phosphodiesterase-5 inhibitors and nitrates. URO Today: Male / Female Sexual Dysfunction-Part 1. Accessible at http://www.urotoday.com/264/conference_reports/selected_abstracts/male__female_sexual_dysfunction__part_1.html . Accessed June 30, 2006.
5. Rashid A: The efficacy and safety of PDE5 inhibitors. Clin Cornerstone 2005, 7:47–56.